Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Areata-like lupus can mimic alopecia areata but is a form of cutaneous lupus erythematosus.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Effective treatments for severe alopecia areata are still lacking.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Scalp dermoscopy is good for diagnosing a type of hair loss and helps choose the best spots for biopsy.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Androgenetic alopecia in women needs more research and better management strategies.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Some chemotherapy can cause permanent hair loss.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Loose Anagen Syndrome is a hair condition where hairs can be easily pulled out, mainly affecting young girls, and may improve on its own or with treatment.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Trichoscopy helps tell apart alopecia areata and trichotillomania in Asians by looking at specific hair and scalp features.